Timing Biotech is a pioneering company focused on the development and commercialization of cutting-edge early cancer detection technologies. Central to its innovation is the breakthrough discovery of tumor-associated micronuclei DNA, first identified by the Timing Biotech team. Building on this unique scientific foundation, the company offers advanced, highly accurate solutions for cancer screening, aiming to detect and cure cancer at its earliest stages. Timing Biotech is committed to making early diagnosis accessible to individuals and organizations worldwide, with a mission to transform global health through early detection and treatment.​